Tuberculosis Demonstration, Research, Public and Professional Education

Active

Assistance listing
93.947
Agency
Grant awards
27 $54,528,219 in federal obligations

Program facts

Assistance types
  • Cooperative Agreement
  • Project Grant
Treasury account
  • 75-0950-0-1-550
More information

Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.

About this program

The Centers for Disease Control and Prevention within the Department of Health and Human Services funds TB demonstration projects, research into prevention and control of tuberculosis nationally and internationally, and training and education activities for TB and latent TB infection (LTBI) under Assistance Listing 93.947, with the most recent grant award dated January 1, 2018.

The program supports regional TB training and medical consultation centers, TB centers of excellence providing education and technical assistance to healthcare workers and TB programs, demonstration projects, and research addressing TB prevention and control. Awarded grants have funded initiatives including the Global Tuberculosis Institute at Rutgers conducting training and education for healthcare workers managing TB and LTBI, the Heartland National TB Center providing technical assistance and medical consultation to TB programs, the Curry International Tuberculosis Center at UCSF supporting TB care and prevention through training and consultation, and international TB control activities in Vietnam and the Democratic Republic of Congo. The program also supports collaborative efforts with international partners on TB prevention and treatment scale-up globally.

Recent funding activity shows 27 total awards spanning from 2002 to 2018, with an average cadence of 2–5 awards annually in the 2006–2018 period. Combined federal dollars obligated total $54.5 million. The CDC was the sole funder across all awards. Awards are predominantly Cooperative Agreements (63 percent, 17 awards) with a smaller share of Project Grants (37 percent, 10 awards). Recent major awards ranged from approximately $9.4 million to $10.1 million per cooperative agreement in January 2018. Regional TB centers of excellence that received January 2018 awards include UCSF's Curry International Tuberculosis Center ($10.1 million), Heartland National TB Center ($10.1 million), and Rutgers Global Tuberculosis Institute ($9.4 million), each with project completion dates of December 31, 2022.

A Cooperative Agreement NOFO (CDC-RFA-PS23-2301) posted November 19, 2021 with a due date of September 6, 2022 solicited applications for up to four regionally-assigned TB Centers of Excellence to conduct training, education, and medical consultation focused on TB and LTBI prevention and control. Applicant eligibility was unrestricted. No currently open funding opportunities are present in the source material as of the most recent opportunity date.

Objective and description

Objective

To assist States, political subdivisions of States, and other public and nonprofit private entities in conducting research into prevention and control of tuberculosis (TB) nationally and internationally. To conduct demonstration projects, provide TB

Description

To assist States, political subdivisions of States, and other public and nonprofit private entities in conducting research into prevention and control of tuberculosis (TB) nationally and internationally. To conduct demonstration projects, provide TB and latent TB infections (LTBI) communication, education, training, medical consultation activities to TB programs, private providers, and other partners for the prevention and control of TB.

Eligibility

Applicant eligibility

States, political subdivisions of States, and other public and nonprofit private entities

Beneficiary eligibility

States, political subdivisions of States, other public and nonprofit private entities, serving persons with TB infection and disease.

Uses of assistance

Requests for direct assistance (i.e., "in lieu of cash") for personnel, equipment, and supplies directly related to project activities, particularly directly observed therapy, patient outreach, and program assessment will be considered. Project funds may not be used to supplant State or local funds available for tuberculosis control or to support construction costs or inpatient care.

Use restrictions

Requests for direct assistance (i.e., "in lieu of cash") for personnel, equipment, and supplies directly related to project activities, particularly directly observed therapy, patient outreach, and program assessment will be considered. Project funds may not be used to supplant State or local funds available for tuberculosis control or to support construction costs or inpatient care.

Length and time phasing of assistance

Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient.

How to apply

Preapplication coordination

Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372.

Criteria for selecting proposals

Applications will be evaluated on the review criteria described in the Notice of Funding Opportunity Announcements (NOFOs). In general, the review and selection process of complete and responsive applications to the NOFO consists of determination of the scientific and technical merit by objective or peer review, availability of funds, and relevance of program priorities and the priorities of CDC.

Award procedure

After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial awards provide funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, award requirements, and special conditions, if any.

Deadlines

Check Grants.gov for any relevant NOFO information regarding processes for applying for assistance.

Renewals

Project period of performance is 1 to 5 years. After initial awards, and subject to availability of funds, projects may be continued non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government.

Grant opportunities

Opportunity Status Posted Applications due
TB Centers of Excellence for Training, Education and Medical Consultation (COE) CDC-RFA-PS23-2301 Closed
Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support II (NAM-PHACTS II) under the President's Emergency Plan for AIDS Relief (PEPFAR) CDC-RFA-GH20-2059 Closed
Partnering with the International Union Against Tuberculosis and Lung Disease to Foster Sustainable and Effective Systems to Strengthen the Delivery of Quality Tuberculosis (TB) Services in Resource Limited Countries CDC-RFA-GH19-1946 Closed
Accelerating the Decline of Tuberculosis (TB) in High Burden Countries and Settings CDC-RFA-GH18-1838 Closed
TB Centers of Excellence for Training, Education, and Medical Consultation (TB COE) CDC-RFA-PS18-1804 Closed
Tuberculosis Regional Training and Medical Consultation Centers CDC-RFA-PS13-130404CONT16 Closed
To Strengthen Collaboration Between CDC & the National TB Controllers Association (NTCA) TB Nurse Coalition Supplement Project CDC-RFA-PS12-12050401SUPP15 Closed
Addressing Global TB And Domestic TB Of All Forms Including TB/HIV In All Populations And In All Settings To Prevent, Control TB And Other Programmatic Activities Involved In Eliminating TB CDC-RFA-PS11-1111 Closed
Addressing TB Control and Lung Health Activities through the Vietnam National Lung Hospital/National TB Program (NLH/NTP) CDC-RFA-PS11-1110 Closed

Grant awards

Latest 10 of 27 listed here. See the rest on GovTribe.

Top recipients by federal obligations

Federal obligations by fiscal year

Fiscal year Federal obligations
FY2024 $3,324,151
FY2023 $18,636,889
FY2022 $8,856,114
FY2021 $8,632,413
FY2020 $15,073,966
FY2019 $10,001,012
FY2018 $5,738,040
FY2017 $5,301,495
FY2016 -$61,382
FY2015 $957,768
FY2014 $6,055,765
FY2013 $2,318,311
FY2012 $1,628,134
FY2011 $1,383,883
FY2009 $855,134
FY2007 $187,145
FY2006 $162,316
FY2004 $158,115
FY2002 $247,395
Show all 19

Quick answers

What is Assistance Listing 93.947?

Assistance Listing 93.947 is Tuberculosis Demonstration, Research, Public and Professional Education, a federal grant program run by Centers for Disease Control and Prevention (Department of Health and Human Services).

What is the CFDA number for Tuberculosis Demonstration, Research, Public and Professional Education?

Its CFDA number is 93.947: Assistance Listing numbers were called CFDA numbers before 2018.

How much funding has Assistance Listing 93.947 awarded?

27 grant awards under 93.947 have obligated $54,528,219 in federal funds to 9 recipients.

Who receives the most funding from 93.947?

The recipients obligated the most under Tuberculosis Demonstration, Research, Public and Professional Education are The University Of Texas Health Science Center At Tyler ($11,684,803), The Regents Of The University Of California. San Francisco ($11,602,795) and University Of Florida ($11,519,670).

Are there open grant opportunities under 93.947?

No opportunity listed under 93.947 is open now. The latest, TB Centers of Excellence for Training, Education and Medical Consultation (COE), was posted on November 19, 2021.

On GovTribe

See this program's full record

  • Every grant award and opportunity under it
  • Funding by recipient, agency and assistance type
  • Alerts for new opportunities
  • Ask GovTribe AI about this program